Jennifer Luft Emerging VTE Clinician Research Award supports early-career scientists and clinicians in patient-oriented blood clot research to improve understanding, treatment, and patient outcomes.
Funder: National Blood Clot Alliance
Due Dates (Anticipated): February 2027 (Application deadline)
Funding Amounts: $20,000 award
Summary: Supports early-career scientists and clinicians advancing patient-oriented venous thromboembolism research and improving patient care and outcomes.
Key Information: Applicants must have a U.S.-based institutional affiliation, be within 10 years of completing a professional degree or clinical training, and rank below associate professor.
The National Blood Clot Alliance (NBCA) established this award in 2023 to recognize outstanding early-career scientists and clinicians advancing the understanding and treatment of venous thromboembolism (VTE) through patient-oriented research. Named in memory of Jennifer Luft, who experienced pulmonary emboli at age 23 and died in 2022, the award focuses on improving care and outcomes for people affected by blood clots.
Research interests include shared decision-making, access to care, quality of life, and health disparities. Applicants may work in basic, translational, clinical, epidemiologic, bioengineering sciences, or any other field, provided their current or planned project is specific to blood clots and patient-oriented. The award can also support professional development and other activities aligned with patient-centered VTE research and clinical science.